Shareholder Information | Diaceutics

Shareholder Information

Number­ of ­Existing ­Ordinary­ Shares in issue: ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­69,583,077

Insofar as the Company is aware, it knows of the following significant shareholders holding more than 3 per cent. of the Company’s issued share capital (last updated 25 March 2019).

Name Number of ordinary shares held % of issued share capital
Peter Keeling* 17,526,049 25.2%
Canaccord Genuity Group Inc 6,839,000 9.8%
Gresham House 5,895,000 8.5%
Elizabeth Considine 5,512,169 7.9%
Universal-Investment-Luxembourg S.A. 3,969,500 5.7%
Philip White** 3,026,330 4.3%
Ryan Keeling 2,890,643 4.2%
Octopus Investments 2,420,500 3.5%
Gordon McKeown 1,941,607 2.8%
Julie Goonwardene Wallin 1,614,127 2.3%
Total 51,619,925 74.2%

 *includes 9,585,659 shares held by Delia Keeling, Peter’s wife prior to admission and 8,861,975 following admission
**includes 1,009,800 shares held by the Philip White Tyres Pension Trust 81810

 

Directors’ Shareholdings

Name Number of ordinary shares held % of issued share capital
Peter Keeling* 17,526,049 25.2%
Ryan Keeling 2,890,643 4.2%
Philip White** 3,026,330 4.3%
Julie Goonwardene Wallin 1,614,127 2.3%
Mike Wort 144,737 0.2%
Charles Hindson 43,500 0.1%
Total 25,230,061 36.3%

*includes 9,585,659 shares held by Delia Keeling, Peter’s wife prior to admission and 8,861,975 following admission
**includes 1,009,800 shares held by the Philip White Tyres Pension Trust 81810

 

Shares not in public hands
A total of 59.8% of the Company’s securities are not traded in public hands.

Statement of the Rights of Shareholders
The rights of shareholders are governed by UK law.

Restrictions in transfer of AIM securities
There are no restrictions on the transfer of the company’s ordinary shares.

UK City Code on Takeovers and Mergers
The Company is subject to the provisions of the City Code on Takeover and Mergers.

Other exchanges and trading platforms
Diaceutics PLC has not applied or agreed to have any of its securities admitted or traded on any other exchanges or platforms.

Shareholder Circulars
Information provided here when available

Latest Corporate News / RNS Announcements

Latest Corporate News / RNS Announcements

Investor Alerts

Subscribe to our investor alert service and receive all press releases, financial results and other key shareholder messages as soon as they become available.

Please enter your name and email address in this form and then click subscribe to add your name to our list.


Please prove you are human by selecting the Heart.

Facebook
Twitter
YouTube
LinkedIn